NCT00533624View on ClinicalTrials.gov

Myfortic vs. Cellcept in Kidney Transplant Recipients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2006

Conditions
End Stage Renal Disease
Interventions
DRUG

Mycophenolate Sodium Delayed Release Tablets

Myfortic® 1,440 mg/day

DRUG

Mycophenolate Mofetil

Cellcept® 2,000 mg/day

Trial Locations (1)

33136

University of Miami Miller School of Medicine, Miami

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Miami

OTHER